8-K: Relay Therapeutics Restructures Cambridge Leases, Anticipates $16 Million in Rent Savings

Relay Therapeutics, Inc. has announced a significant real estate restructuring, terminating its Binney Street lease early and entering a new Kendall Square lease, projected to save approximately $16 million in rent expenses.

Summary

• Relay Therapeutics, Inc. (the "Company") entered into a Third Amendment to its Lease Agreement for 399 Binney Street, Cambridge, Massachusetts, accelerating its termination.
• The Binney Street Lease, covering 46,631 square feet of laboratory and office space, was originally scheduled to expire on April 30, 2029.
• The early termination date will be 30 days after an affiliate of the Landlord tenders possession of new premises to the Company under the Kendall Square Lease.
• In consideration for the early termination, the Company paid a lease modification fee of approximately $2.5 million and agreed to transfer title of certain furniture, fixtures, and equipment to the Landlord.
• Concurrently, the Company entered into a new Kendall Square Lease for approximately 12,190 square feet of office space at Building 300, One Kendall Square, Cambridge, Massachusetts, with a base term until February 28, 2030.
• A relocation payment of approximately $3.5 million was made for the new Kendall Square Lease.
• The combined effect of these lease changes is expected to result in a reduction of approximately $16 million in rent expense over the course of the lease commitments.
• The Company continues to lease 41,474 square feet at 60 Hampshire Street, Cambridge, Massachusetts, which serves as its current corporate headquarters, with a term through June 30, 2032.

Sentiment

Score: 7

Explanation: The lease restructuring, despite upfront costs, is projected to yield significant long-term rent savings ($16 million), indicating a positive financial optimization strategy. The reduction in space could imply efficiency or a shift in operational needs, which is generally positive for cost management.

Positives

• Anticipated reduction of approximately $16 million in rent expense over the course of the lease commitments, indicating long-term cost efficiency.
• Optimization of real estate footprint by reducing leased space at one location while securing a new, smaller office space in a key biotech hub (Kendall Square).

Negatives

• Incurred a lease modification payment of approximately $2.5 million for the early termination of the Binney Street Lease.
• Incurred a relocation payment of approximately $3.5 million for the new Kendall Square Lease.
• Transfer of title of certain furniture, fixtures, and equipment to the Landlord as part of the termination agreement.

Future Outlook

The company anticipates a reduction of approximately $16 million in rent expense over the course of its lease commitments as a result of these real estate changes. The new Kendall Square lease extends until February 28, 2030.

Industry Context

This real estate restructuring suggests a strategic optimization of office and laboratory space, potentially reflecting evolving operational needs or a focus on cost efficiency within the biotechnology sector, particularly in high-cost areas like Cambridge, Massachusetts. Companies often adjust their physical footprint to align with R&D pipeline stages, workforce size, and financial strategies.

Related Party Transactions

• The new Kendall Square Lease is with ARE MA Region No. 59, LLC, an affiliate of ARE MA Region No. 58, LLC, the Landlord of the terminated Binney Street Lease.

Stakeholder Impact

• Shareholders: Potential positive impact due to anticipated long-term rent expense reduction, which could improve profitability and cash flow.
• Employees: Relocation of some office space may impact employees previously working at the Binney Street location, though the primary headquarters remains at 60 Hampshire Street.

Next Steps

• The Lease Amendment will be filed with the Company's Quarterly Report on Form 10-Q for the period ended June 30, 2025.
• The early termination of the Binney Street Lease will occur 30 days after ARE MA Region No. 59, LLC tenders possession of the Kendall Square premises to the Company.

Key Dates

Recommendation

Keywords

Relay Therapeutics, SEC Filing, 8-K, Lease Agreement, Real Estate, Cambridge, Biotechnology, Office Space, Laboratory Space, Rent Expense, Corporate Headquarters, Financial Savings